Related Experiment Video

Updated: May 16, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Lentivirus-mediated shRNA interference targeting SLUG inhibits lung cancer growth and metastasis

Yao-Peng Wang1, Ming-Zhao Wang, Yi-Ren Luo

  • 1Department of Thoracic Surgery, Affiliated Hospital of Medical College Qingdao University, Qingdao, Shandong, China.

Asian Pacific Journal of Cancer Prevention : APJCP
|December 19, 2012
PubMed
Abstract

Insights

SLUG (SNAI2) knockdown significantly inhibits lung cancer cell proliferation, invasion, and metastasis. This study identifies SLUG as a potential therapeutic target for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Lung cancer is the leading cause of cancer-related deaths globally.
  • The gene SLUG (SNAI2) plays a role in epithelial-mesenchymal transition and is implicated in lung cancer progression.

Purpose of the Study:

  • To investigate the role of SLUG in non-small cell lung cancer (NSCLC) progression.
  • To evaluate SLUG as a potential therapeutic target for lung cancer.

Main Methods:

  • Constructed lentivirus vector with SLUG shRNA (LV-shSLUG).
  • Infected A549 NSCLC cells with LV-shSLUG and control lentivirus.
  • Assessed SLUG expression using real-time PCR, Western blot, and IHC.
  • Evaluated cell proliferation and migration using MTT and colony formation assays.

Main Results:

  • Confirmed SLUG knockdown by approximately 80-90% at mRNA and protein levels.
  • SLUG knockdown significantly suppressed lung cancer cell proliferation.
  • SLUG knockdown inhibited cancer cell invasion and metastasis.
  • Induced down-regulation of Bcl-2 and up-regulation of E-cadherin.

Conclusions:

  • SLUG is a newly identified gene associated with lung cancer growth and metastasis.
  • SLUG inhibition suppressed tumor progression in NSCLC cells.
  • SLUG represents a promising therapeutic target for future lung cancer treatments.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells09:12

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells

Published on: December 21, 2011

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...